Global Key SolutionsGKS
Guidance Documents/Guidance-Document/Advanced Prostate Cancer: Developing Gonadotropin-Releasing Hormone Analogues Guidance for Industry: Clinical/Medical

Advanced Prostate Cancer: Developing Gonadotropin-Releasing Hormone Analogues Guidance for Industry: Clinical/Medical

Detailed guidance document from FDA and regulatory agencies.

Document Details

Guidance Document

May 27, 2022

May 26, 2022

Center for Drug Evaluation and Research

3000f20b-5abd-4861-8188-ffcc1d35913d

Related Documents

Bladder Cancer: Developing Drugs and Biologics for Adjuvant Treatment: Guidance for Industry

Guidance DocumentJune 28, 2022Office of the Commissioner
View Details →

Renal Cell Carcinoma: Developing Drugs and Biologics for Adjuvant Treatment: Guidance for Industry

Guidance DocumentJune 27, 2022Office of the Commissioner
View Details →

Eosinophilic Esophagitis: Developing Drugs for Treatment Guidance for Industry

Guidance DocumentSeptember 15, 2020Center for Drug Evaluation and Research
View Details →

Quick Actions

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
[email protected]
Quick Links
KeyPedia™ Lite
Legal & Ethics
©2026, Global Key Solutions All rights reserved.